Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis Toward Therapy for Glaucoma

Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis : Toward Therapy for Glaucoma

© 2017 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 29(2017), 16 vom: 27. Apr.
1. Verfasser: Chandrawati, Rona (VerfasserIn)
Weitere Verfasser: Chang, Jason Y H, Reina-Torres, Ester, Jumeaux, Coline, Sherwood, Joseph M, Stamer, W Daniel, Zelikin, Alexander N, Overby, Darryl R, Stevens, Molly M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article glaucoma layer-by-layer capsules liposomes nitric oxide β-galactosidase Nitric Oxide 31C4KY9ESH
LEADER 01000naa a22002652 4500
001 NLM269159886
003 DE-627
005 20231224224028.0
007 cr uuu---uuuuu
008 231224s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201604932  |2 doi 
028 5 2 |a pubmed24n0897.xml 
035 |a (DE-627)NLM269159886 
035 |a (NLM)28221702 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Chandrawati, Rona  |e verfasserin  |4 aut 
245 1 0 |a Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis  |b Toward Therapy for Glaucoma 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 15.01.2019 
500 |a Date Revised 12.11.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2017 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a Nitric oxide (NO) is able to lower intraocular pressure (IOP); however, its therapeutic effects on outflow physiology are location- and dose-dependent. A NO delivery platform that directly targets the resistance-generating region of the conventional outflow pathway and locally liberates a controlled dose of NO is reported. An increase in outflow facility (decrease in IOP) is demonstrated in a mouse model 
650 4 |a Journal Article 
650 4 |a glaucoma 
650 4 |a layer-by-layer capsules 
650 4 |a liposomes 
650 4 |a nitric oxide 
650 4 |a β-galactosidase 
650 7 |a Nitric Oxide  |2 NLM 
650 7 |a 31C4KY9ESH  |2 NLM 
700 1 |a Chang, Jason Y H  |e verfasserin  |4 aut 
700 1 |a Reina-Torres, Ester  |e verfasserin  |4 aut 
700 1 |a Jumeaux, Coline  |e verfasserin  |4 aut 
700 1 |a Sherwood, Joseph M  |e verfasserin  |4 aut 
700 1 |a Stamer, W Daniel  |e verfasserin  |4 aut 
700 1 |a Zelikin, Alexander N  |e verfasserin  |4 aut 
700 1 |a Overby, Darryl R  |e verfasserin  |4 aut 
700 1 |a Stevens, Molly M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 29(2017), 16 vom: 27. Apr.  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:29  |g year:2017  |g number:16  |g day:27  |g month:04 
856 4 0 |u http://dx.doi.org/10.1002/adma.201604932  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 29  |j 2017  |e 16  |b 27  |c 04